Use of Convalescent Plasma Therapy in Two COVID-19 Patients with Acute Respiratory Distress Syndrome in Korea (scientific article published on 13 April 2020)

The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis

Q27001157

Ebola virus convalescent blood products: where we are now and where we may need to go.

Q30369241

Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection.

Q30398715

MERS-CoV Antibody Responses 1 Year after Symptom Onset, South Korea, 2015.

Q33908067

Multiple organ infection and the pathogenesis of SARS.

Q33988914

Enhanced clearance of HIV-1-infected cells by broadly neutralizing antibodies against HIV-1 in vivo

Q34527478

Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients

Q40523218

Treatment of severe acute respiratory syndrome with convalescent plasma

Q40557957

Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome

Q43519559

Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patients.

Q44950223

Corticosteroid Therapy for Critically Ill Patients with the Middle East Respiratory Syndrome

Q45073537

Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury

Q84649317

SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients

Q89779929

Convalescent plasma as a potential therapy for COVID-19

Q89954633

Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China

Q90296811

Autopsy in suspected COVID-19 cases

Q90539057

Viral dynamics in mild and severe cases of COVID-19

Q90564410

P275

Creative Commons Attribution-NonCommercial 4.0 International

copyrighted

issue

language of work or name

English

Q1860

P921

main subject

acute respiratory distress syndrome

COVID-19

SARS-CoV-2

convalescent plasma

page(s)

e149

P577

publication date

2020-04-13

P1433

published in

Journal of Korean Medical Science

Q24039955

P1476

title

Use of Convalescent Plasma Therapy in Two COVID-19 Patients with Acute Respiratory Distress Syndrome in Korea

P478

volume

Reverse relations

cites work (P2860)

Q99248437	Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies
Q98770823	COVID-19 Presentation in Association with Myasthenia Gravis: A Case Report and Review of the Literature
Q98498401	COVID-19 Vaccine: A comprehensive status report
Q97642226	Clinical efficacy of convalescent plasma for treatment of COVID-19 infections: Results of a multicenter clinical study
Q99240876	Convalescent Plasma Therapy and Its Effects On COVID-19 Patient Outcomes: A Systematic Review of Current Literature
Q99238028	Convalescent Plasma: A Potential Life-Saving Therapy for Coronavirus Disease 2019 (COVID-19)
Q99233179	Convalescent plasma as a treatment modality for coronavirus disease 2019 in Sudan
Q94539926	Convalescent plasma in Covid-19: Possible mechanisms of action
Q98950575	Convalescent plasma treatment for COVID-19: tempering expectations with the influenza experience
Q97084237	Diabetes and COVID-19: Global and Regional Perspectives
Q96292722	Evaluation of the EDI enzyme linked immunosorbent assays for the detection of SARS-CoV-2 IgM and IgG antibodies in human plasma
Q96769344	Helping doctors hasten COVID-19 treatment: Towards a rescue framework for the transfusion of best convalescent plasma to the most critical patients based on biological requirements via ml and novel MCDM methods
Q98906910	Human immunology and immunotherapy: main achievements and challenges
Q97068390	Life-saving effect of convalescent plasma treatment in covid-19 disease: Clinical trial from eastern Anatolia
Q101142407	Multi-omics-based identification of SARS-CoV-2 infection biology and candidate drugs against COVID-19
Q99633101	Patients with Prolonged Positivity of SARS-CoV-2 RNA Benefit from Convalescent Plasma Therapy: A Retrospective Study
Q97438796	Potential effective treatment for COVID-19: systematic review and meta-analysis of the severe infectious disease with convalescent plasma therapy
Q98577501	Quantifying absolute neutralization titers against SARS-CoV-2 by a standardized virus neutralization assay allows for cross-cohort comparisons of COVID-19 sera
Q99203763	Recent advances in use of fresh frozen plasma, cryoprecipitate, immunoglobulins, and clotting factors for transfusion support in patients with hematologic disease
Q103732534	Review of registered clinical trials for the treatment of COVID-19
Q94547370	Role of adjunctive treatment strategies in COVID-19 and a review of international and national clinical guidelines
Q97536710	SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy
Q98944371	SARS-CoV-2 serology and virology trends in donors and recipients of convalescent plasma
Q97545650	The Emerging Role of Convalescent Plasma in the Treatment of COVID-19
Q100464001	The efficacy assessment of convalescent plasma therapy for COVID-19 patients: a multi-center case series
Q98200267	The immune system as a target for therapy of SARS-CoV-2: A systematic review of the current immunotherapies for COVID-19
Q94669065	The role of passive immunization in the age of SARS-CoV-2: an update
Q98460873	Treatment of COVID-19 with convalescent plasma: lessons from past coronavirus outbreaks
Q98771813	Treatment of COVID-19: Perspective on Convalescent Plasma Transfusion

P8150	COVIDWHO ID	covidwho-47979
P6179	Dimensions Publication ID	1126637828
P356	DOI	10.3346/JKMS.2020.35.E149
P932	PMC publication ID	7152526
P698	PubMed publication ID	32281317